NCT02916706View on ClinicalTrials.gov

Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

August 14, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Teneligliptin 20mg

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational center, Beijing

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY